Quantum Life Sciences (QLS) is a new field at the intersection of quantum technology, artificial intelligence (AI) and life sciences. This combination can dramatically accelerate the development of personalized medicine and medical innovations. To highlight these opportunities, we have prepared a white paper with a number of partners. You can find it in this attachment: Quantum Life Sciences Key Region Leiden.
Pilot region Quantum software
- In our white paper“Quantum Life Sciences: Key Region Leiden,” we argue that the key lies not in hardware, but in quantum software and algorithms, accounting for an estimated 94% of future market value. Quantum software enables high-precision molecule simulations and more efficient drug development.
- Leiden has everything it needs to act as a European pilot region: top expertise in quantum(Leiden Hub | Quantum Delta NL), AI (LIACS) and life sciences(Leiden Bio Science Park), complemented by the new House of Quantum, location Bio Partner 4.
- Key Region Leiden is calling on Europe to strategically invest in quantum software within the European Quantum Act to accelerate the translation of European innovations into concrete health solutions.
Call to Europe
A delegation from Key Region Leiden paid an inspiring visit to Brussels for the European Week of Regions and Cities. There we proudly presented our white paper on Quantum Life Sciences. Together with Leiden Bio Science Park and the Applied Quantum Algorithms group at Leiden University, we made an appeal to Europe to invest in quantum software for innovation in health and biotechnology. We are happy to enter into collaborations to take this further.
Also read our recap of the visit to Brussels.
